Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

A trial of lixisenatide to assess its effects in early Parkinson’s disease.

Occupational exposure to reinforced concrete production is associated with adverse respiratory health

The exposure to fine particulate matter (PM) in reinforced concrete production.

September 21, 2023

Opinion | Closing Gender-Based Disease Disparities Starts in the Lab

Despite the fact men have lower life expectancy than women and are at a higher risk of developing serious health conditions like heart disease and

April 28, 2024

J&J and Astellas pile on two more biopharma industry lawsuits over CMS drug price negotiations

Johnson & Johnson and Astellas are joining with their pharma heavyweight peers Bristol Myers Squibb, Merck, industry group PhRMA and the US Chamber of Commerce

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.